MaTOMS: A Feasibility Study Into Collecting Major Trauma Outcomes
MaTOMS
1 other identifier
observational
70
1 country
1
Brief Summary
Major Trauma Outcome Measures Study (MaTOMS): A feasibility Study into using outcome measures in major trauma patients. At present patients who suffer major trauma (multiple, serious injuries that could result in death or serious disability e.g. serious head injuries and multiple fractures), are now able to survive due to advances in modern medicine. Unfortunately they may be left with long term disabilities such as problems with performing day to day activities. We currently do not know how bad these disabilities are or have any way of judging any differences between the outcomes of different hospitals. MaTOMS is a feasibility study taking place in one hospital, the John Radcliffe Hospital which aims to help answer these questions by developing a set of structured interviews that can be used after an injury to find out about patient outcomes. It will identify how difficult or easy it is to collect the data and information outlined in this project, and whether the types of data and information collected as part of the interviews are a good indicator of a patient's outcomes. Over 30 months the study will recruit up to 100 patients who are aged 2 years and over who have been admitted following major trauma. Major trauma will be defined as a score of 9 or more on the Injury Severity Score, a widely used system to stratify those who suffer an injury. Those who agree to take part following a consent process will undergo structured interviews both in hospital and twice via telephone in the year following discharge. Some participants will take part in an additional interview either asking about their experience of answering the questions during the structured interview or exploring their experience and feelings about their traumatic injury to see if our structured interviews are missing any aspect of their experience. The main objectives for this feasibility study is to test the feasibility of routine collection of outcome measurement data following major trauma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2013
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 21, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2016
CompletedFirst Posted
Study publicly available on registry
September 11, 2017
CompletedSeptember 11, 2017
September 1, 2017
3.1 years
January 21, 2015
September 6, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
EQ-5D
Quality of life
12 months
Secondary Outcomes (4)
SF12
12 months
GOS-E
12 months
FIM
12 months
Pain Score
12 months
Interventions
No Intervention as it is an observational study
Eligibility Criteria
All patients aged 2 or over who are admitted to the study centre with a diagnosis that is encompassed by the definition of major trauma (Injury Severity Score greater than or equal to 9) following injury will be eligible for the study as long as they are enrolled less than 4 weeks following the injury and consent to participate.
You may qualify if:
- Male or female
- Over 2 years
- First admission (for a particular set of injuries) to the Major Trauma Centre
- Traumatic injuries with ISS 9 or more as estimated at time of eligibility assessment
- Within 4 weeks of injury
You may not qualify if:
- The participant may not enter the study if ANY of the following apply:
- Non resident in the United Kingdom
- Patient unwilling to give informed consent
- Patient unable to give informed consent and 'consultee' advises they feel patient would not be content to participate
- Inmate in prison and therefore unable to be easily followed up by telephone
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Oxford University Hospital Trust
Oxford, OX3 9DU, United Kingdom
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Keith Willett
Oxford University Hospital Trust
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Research Fellow
Study Record Dates
First Submitted
January 21, 2015
First Posted
September 11, 2017
Study Start
April 1, 2013
Primary Completion
May 1, 2016
Study Completion
October 1, 2016
Last Updated
September 11, 2017
Record last verified: 2017-09